Laboratorios Farmaceuticos Rovi financials at a glance

The revenue of Laboratorios Farmaceuticos Rovi is reported as 0.8295 billion Euro in the fiscal year 2023. The earnings were 3.21 Euro per share in 2023, which was 13.94 lower than 2022. And about 0.05946 billion Euro are reported as free cash flow in the financials of Laboratorios Farmaceuticos Rovi 2023. Dividends of 1.1 Euro per share were paid to shareholders of Laboratorios Farmaceuticos Rovi stock BME:ROVI in fiscal 2023.